The price of Kerendia (finerenone) 20 mg can vary significantly depending on factors such as insurance coverage, pharmacy, and location.
How much does Kerendia 20 mg cost without insurance?
Without insurance, a 30-day supply of Kerendia 20 mg can range from approximately $550 to over $600 [1]. This price reflects the average retail cost and does not account for potential discounts or patient assistance programs.
What factors influence the price of Kerendia?
The retail price of Kerendia is influenced by manufacturing costs, research and development expenses, and market demand. Additionally, insurance formularies and copayments play a major role in the out-of-pocket cost for patients.
Are there any patient assistance programs for Kerendia?
Bayer, the manufacturer of Kerendia, offers a program called Bayer Bridge to Rx. This program can provide eligible commercially insured patients with free medication for a limited time if they experience delays in their insurance coverage or have high copays [2]. Information on eligibility and enrollment is available through the manufacturer's patient support services.
When does the Kerendia patent expire?
Patent protection for drugs like Kerendia is crucial for maintaining market exclusivity and recouping development costs. Information on specific patent expiry dates for Kerendia can be found on specialized drug patent databases [3]. Generally, patent expirations pave the way for generic competition, which can lead to lower prices.
What are the alternatives to Kerendia?
Kerendia is used to reduce the risk of sustained estimated glomerular filtration rate (eGFR) decline, kidney disease progression, cardiovascular events, and cardiovascular death in adults with chronic kidney disease associated with type 2 diabetes. Current treatment guidelines and clinical practice may involve a combination of therapies aimed at managing blood pressure, blood sugar, and other risk factors for kidney disease progression. The availability and efficacy of alternative treatments, including generic medications for underlying conditions, can impact treatment decisions.